Načítá se...
Anti-angiogenic Therapy for Retinal Disease
Recent breakthroughs in our understanding of the molecular pathophysiology of retinal vascular disease have allowed us to specifically target pathological angiogenesis while minimizing damage to the neurosensory retina. This is perhaps best exemplified by the development of therapies targeting the p...
Uloženo v:
| Vydáno v: | Handb Exp Pharmacol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5451313/ https://ncbi.nlm.nih.gov/pubmed/27783271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/164_2016_78 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|